Suchergebnisse - "Fontana, Diletta"

PubPharm (30)

1

Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients

enthalten in: bioRxiv.org | 2024

von Fontana, D. | Crespiatico, I. | Crippa, V. | +11

2

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

enthalten in: Blood | 2024

von Crespiatico, I. | Zaghi, M. | Mastini, C. | +37

CommentIn: Blood. 2024 Apr 4;143(14):1323-1324. - PMID 38573606

3

Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration : a case report with insights on the molecular landscape

enthalten in: Annals of hematology | 2024

von Fontana, D. | Zambrotta, G. | Scannella, A. | +2

4

New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients

enthalten in: NPJ precision oncology | 2024

von Villa, M. | Malighetti, F. | Sala, E. | +12

5

Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape

enthalten in: Annals of hematology | 2024

von Fontana, D. | Zambrotta, G. | Scannella, A. | +2

6

Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients

enthalten in: Nature communications | 2023

von Fontana, D. | Crespiatico, I. | Crippa, V. | +11

7

Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era : A Focused Review

enthalten in: Cancers | 2023

von Fontana, D. | Elli, E. | Pagni, F. | +1

8

Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine : A single-center prospective observational study (NCT05074706)

enthalten in: EJHaem | 2022

von Bossi, E. | Aroldi, A. | Borin, L. | +14

9

Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia

enthalten in: American journal of hematology | 2022

von Gambacorti-Passerini, C. | Nicolini, F. | Larson, R. | +6

10

Validation of a new NGS-based myeloid panel in acute myeloid leukemia : A single-center experience

enthalten in: Leukemia research | 2022

von Steidl, C. | Aroldi, A. | Mologni, L. | +9